Healthcare
Live Price
Offline$4.00
+0.00% today
1Y Change
-73.51%
Window
Jun 23, 2025 → Jun 19, 2026
Coverage: 255 bars · Jun 23, 2025 → Jun 19, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Surgical Science Sweden AB (publ) (SUSRF) is a Healthcare stock with a market cap of $1.67B and listed on OTC. The stock last traded around $4.00 and down 73.5% across the available one-year price window (Jun 23, 2025 → Jun 19, 2026). Baseline metrics include revenue growth of +12.0%, EPS growth of -50.0%, a dividend yield of 0.0%. What stands out right now is revenue +12.0%, EPS -50.0%, free cash flow -24.2% with operating margin 7.6% and ROIC 1.1%. Valuation is more restrained than many high-expectation growth names at P/E 25.1 and price/sales 1.7. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines SUSRF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SUSRF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
SUSRF Max Drawdown
-81.64%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for SUSRF and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.